Preclinical studies have shown that inhibition of PRMT5 activity suppresses tumor cell proliferation in vitro and in animal models slows tumor growth and prolongs survival, suggesting that PRMT5 provides a target for cancer therapy15,16. The gene discussed is PRMT5; the disease is cancer.